| Latest | F'cast | |
|---|---|---|
| Div Yield | 2.5% | 0.0% |
| Div Cover | 2.4 | 2.5 |
| Op Mrgn | 13.0% | 22.4% |
| ROCE | 26.6% |
| Latest | F'cast | |
|---|---|---|
| P/E | 16.5 | 17.4 |
| PEG | 1.1 | 1.4 |
| Pr/Revenue | 2.5 | 2.0 |
| Pr/Book | 4.0 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 6.6% | -21.0% |
| PBT | -6.5% | 88.1% |
| EPS | 15.7% | 11.3% |
| DPS | 12.9% | -37.8% |
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-21 | 2,038.30 | 151.30 | 13.10¢ | 19.5 | 2.4 | +8% | 5.87¢ | 2.3% |
| 31-Dec-22 | 2,072.50 | 81.90 | 12.70¢ | 24.3 | n/a | -3% | 6.05¢ | 2.0% |
| 31-Dec-23 | 2,142.40 | 167.40 | 13.40¢ | 24.1 | 4.0 | +6% | 6.23¢ | 1.9% |
| 31-Dec-24 | 2,289.00 | 246.00 | 15.30¢ | 19.2 | 1.4 | +14% | 6.42¢ | 2.2% |
| 31-Dec-25 | 2,439.00 | 230.00 | 17.70¢ | 18.2 | 1.1 | +16% | 7.24¢ | 2.2% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-26 | 2,553.79 | 573.03 | 14.87p | 15.8 | 1.4 | +11% | 5.97p | 0.0% |
| 31-Dec-27 | 2,730.27 | 650.49 | 16.98p | 13.8 | 1.0 | +14% | 6.82p | 0.0% |
Copyright © 2026 FactSet Research Systems Inc. All rights reserved.
| Director/PDMR Shareholding | 14-Oct-2026 | 11:00 | RNS |
| Transaction in Own Shares | 12-Oct-2026 | 11:00 | RNS |
| Transaction in Own Shares | 05-Oct-2026 | 11:00 | RNS |
| Convatec raises outlook with new specialist medi... | 25-Feb-2026 | Times |
| Traded | Action | Notifier | Price | Amount | Value |
|---|---|---|---|---|---|
| 13-Oct-26 | Buy | Jens Viebke | 229.80p | 24,400 | £56,071.20 |
| 06-Aug-26 | Buy | Tobias Hestler | 225.80p | 50,000 | £112,899.99 |
| Currency | UK Pounds |
| Share Price | 234.80p |
| Change Today | 0.20p |
| % Change | 0.09 % |
| 52 Week High | 256.40 |
| 52 Week Low | 194.00 |
| Volume | 1,067,062 |
| Shares Issued | 1,912.23m |
| Market Cap | £4,489.92m |
| Beta | 0.00 |
| RiskGrade | 96 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income |
|
|---|
| Growth |
|
|---|
| Strong Buy | 8 |
| Buy | 7 |
| Neutral | 2 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 17 |

| Latest | Previous | |
|---|---|---|
| Interim | Final | |
| Ex-Div | 20-Aug-26 | 16-Apr-26 |
| Paid | 30-Sep-26 | 28-May-26 |
| Amount | 2.17¢ | 5.37¢ |
| Time | Volume / Share Price |
| 12:50 | 11 @ 234.80p |
| 12:50 | 87 @ 234.80p |
| 12:50 | 87 @ 234.80p |
| 12:48 | 1,328 @ 234.80p |
| 12:48 | 819 @ 234.80p |
| Chair | John McAdam |
| CEO | Jonny Mason |
| CFO | Fiona Ryder |
You are here: research